FMR1 and fragile X syndrome: Our FXS focus has shifted to the extracellular synaptomatrix owing to identification of pharmacological and genetic interactions between FMRP and secreted MMPs (Siller and Broadie, 2011), a mechanism that is conserved in mammals (Bilousova et al., 2009; Siller and Broadie, 2012).